Abstract:
The invention relates to acrylic hydrogels comprising highly anisotropic gold nanoparticles, and to methods for preparing the same. The hydrogels of the invention are characterised by a light transmittance minimum at the 532-652 nm range of the electromagnetic spectrum and photothermal responsiveness to 808 nm wavelength irradiation.
Abstract:
The invention relates to a composition comprising at least one nanoparticle, wherein each nanoparticle preferentially comprises an iron oxide mineral core surrounded by a coating, wherein the composition further comprises a cryo-protectant or a compound that protects or maintains at least one property of the composition, wherein the core comprises a first center activity, CA1, and/or wherein the coating comprises a second center of activity, CA2, wherein CA1 and CA2 are preferentially selected in the group consisting of: A) a radio-sensitizer or amplifier of radiation, a radio-photosensitizer or amplifier of light radiation, an acoustic sensitizer or amplifier of acoustic radiation or wave, a sonosensitizer or amplificatory of acoustic wave, a particle radiation sensitizer or amplifier of particle radiation, where the particle comprises (or not) a mass, it is a thermal-sensitizer or amplifier of heat or cold or thermal treatment, an amplifier of the medical effect of a compound, and B) an attenuator of radiation, of light radiation, of acoustic radiation or wave, of particle radiation, where the particle comprises (or not) a mass, of heat or cold, of thermal treatment, and/or of the medical effect of a compound.
Abstract:
The disclosure pertains to mixtures of LaFeSiH magnetic nanoparticles having different Curie temperatures useful for improved inductive hyperthermia efficiency, injectable formulations containing the nanoparticles, and methods of raising the temperature of selected cells using the nanoparticles.
Abstract:
The present invention provides amphiphilic telodendrimers that aggregate to form nanocarriers characterized by a hydrophobic core and a hydrophilic exterior. The nanocarrier core may include amphiphilic functionality such as cholic acid or cholic acid derivatives, and the exterior may include branched or linear poly(ethylene glycol) segments. Nanocarrier cargo such as hydrophobic drugs and other materials may be sequester in the core via non-covalent means or may be covalently bound to the telodendrimer building blocks. Telodendrimer structure may be tailored to alter loading properties, interactions with materials such as biological membranes, and other characteristics.
Abstract:
Disclosed herein are iron oxide nanoparticles having an iron (II) content in a metastable state that is intermediate the iron (II) content of wüstite and magnetite. The disclosed iron oxide nanoparticles exhibit unexpectedly beneficial magnetic properties (e.g., saturation magnetization) resulting from both the size of the nanoparticles and the iron (II) content. Accordingly, the iron oxide nanoparticles are attractive for magnetic imaging applications, such as magnetic particle imaging. Methods of forming the iron oxide nanoparticles are also provided, such methods including a controlled oxidation step wherein a small amount (e.g., 1%) of gaseous oxygen is exposed to wüstite nanoparticles for a defined period of time sufficient to partially oxidize the wüstite but prevent conversion entirely to magnetite. Finally, methods of using the iron oxide nanoparticles are also provided. Representative methods include magnetic particle imaging, magnetic resonance imaging, and hyperthermia.
Abstract:
This invention concerns a composition comprising at least one association of at least one magnetic nanoparticle and at least one substance, wherein the association is activated by radiation, for use in a treatment by radiation for destroying at least one pathological cell in an individual, comprising administering the composition at a body site of an individual and performing at least one type of activation of the association by radiation to activate magnetic nanoparticles without producing any temperature increase, whereby the pathological cell destruction occurs at the administration site and away from this site beyond the association diffusion region.
Abstract:
The present disclosure relates to emissive polymeric matrices and methods of using them. The emissive polymeric matrices comprise a monomer such as, for example, 2- hydroxyehtyl methacrylate (HEMA) and at least one chromophore.
Abstract:
The present invention relates to an apyrogenic preparation containing nanoparticles synthesised by magnetotactic bacteria for medical or cosmetic applications. The nanoparticles according to the invention consist of a central crystallised mineral portion mostly comprising an iron oxide, and a peripheral coating not comprising material originating from magnetotactic bacteria.